Literature DB >> 23653007

Screening and test of CD40 related signal transduction pathway in AGS cells and construction of gene silencing vector.

Rui Li1, Wei-Chang Chen, Xue-Qin Pang, Wen-Yan Tian, Wei-Peng Wang, Xue-Guang Zhang.   

Abstract

This study is designed to screen the CD40 related signal transduction pathway in AGS cells and construction of gene silencing vector. Analysis results showed 414 differential genes expression, including upregulation of 209 genes and downregulation of 205 genes. Basing on the ratio of signal in experimental group to signal in control group, 45 genes (38 genes upregulation and seven genes downregulation) with significant (P<0.01) change in expression levels were screened according to the screening standard (signal log ratio≥1 or ≤-1). These genes involved into metabolism, cell cycle and apoptosis, signal transduction and stress response. Furthermore, PI3K mRNA expression level in PI3K siRNA transfected AGS cells was 0.2335±0.0116 72 h after transfection. This value was significantly (P<0.05) lower than that in blank and negative control groups. PI3K protein expression in PI3K siRNA transfected AGS cells was significantly (P<0.05) lower than that in blank and PI3K siRNA/N transfected groups. Therefore, PI3K siRNA gene silencing vector can significantly inhibit PI3K mRNA and protein expression in AGS cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23653007     DOI: 10.1007/s11033-013-2579-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

Review 1.  Gene silencing by double-stranded RNA.

Authors:  R W Carthew
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

2.  Genetic interference in Trypanosoma brucei by heritable and inducible double-stranded RNA.

Authors:  H Shi; A Djikeng; T Mark; E Wirtz; C Tschudi; E Ullu
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

3.  Transcriptional silencing and promoter methylation triggered by double-stranded RNA.

Authors:  M F Mette; W Aufsatz; J van der Winden; M A Matzke; A J Matzke
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

4.  Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo.

Authors:  Victor M Bondar; Bridget Sweeney-Gotsch; Michael Andreeff; Gordon B Mills; David J McConkey
Journal:  Mol Cancer Ther       Date:  2002-10       Impact factor: 6.261

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors.

Authors:  S Roche; M Koegl; S A Courtneidge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  CD40 signaling activated by agonistic anti-CD40 monoclonal antibody 5C11 has different effects on biological behavior of gastric carcinoma cells.

Authors:  Rui Li; Wei-chang Chen; Wei-peng Wang; Wen-yan Tian; Xue-guang Zhang
Journal:  Immunol Lett       Date:  2010-02-25       Impact factor: 3.685

9.  Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.

Authors:  R Shivakrupa; Alan Bernstein; Nicole Watring; Diana Linnekin
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.

Authors:  Zachary A Knight; Beatriz Gonzalez; Morri E Feldman; Eli R Zunder; David D Goldenberg; Olusegun Williams; Robbie Loewith; David Stokoe; Andras Balla; Balazs Toth; Tamas Balla; William A Weiss; Roger L Williams; Kevan M Shokat
Journal:  Cell       Date:  2006-04-27       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.